Skip to main content Skip to main navigation menu Skip to site footer
Experimental Oncology
  • Home
    • About this Journal
    • Privacy Statement
    • Open access policy
    • Cost of publication
    • Guides for authors
  • Current
  • Archives
  • Editorial Board
  • Submissions
  • Archive 2018-2006
  • Contact
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

Found 217 items.
  • INTERPLAY OF LNCRNAS, METABOLIC CELL DEATH, AND IMMUNE MICROENVIRONMENT IN GENITOURINARY MALIGNANCIES

    V. Gordiiuk, L. Shevchenko, D. Todoryshyn, V. Kashuba, O. Mankovska
    143-155
    07.10.2025
    DOI: https://doi.org/10.15407/exp-oncology.2025.02.143
  • CLINICAL SIGNIFICANCE OF SALIVARY MIR-21, -155, AND -375 IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF ORAL CAVITY

    O. BURTYN, T. BORIKUN, O. ROSSYLNA, A. KOPCHAK, О. KRAVETS
    139-145
    09.10.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.02.139
  • Quality of Life Assessed by the Questionnaire MOS SF-36 in Bladder Cancer Patients Depending on the Method of Surgical Treatment

    P. YAKOVLEV, V. KUTS, S. ZEMSKOV, R. VERESHCHAKO
    351-357
    12.12.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.04.351
  • The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer

    Y.V. Dumanskiy, O.V. Bondar, E.A. Stoliarchuk
    176-178
    05.06.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-2.13303
  • Human microbiota and effectiveness of cancer chemotherapy

    Yu.V. Shvets, N.Yu. Lukianova, V.F. Chekhun
    82-93
    01.06.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14611
  • LETROZOLE IMPROVES PROGRESSION-FREE SURVIVAL OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH PEGYLATED LIPOSOMAL DOXORUBICIN AND MAGNETOTHERMY

    A. Loboda, O. Movchan, I. Smolanka (Sr), Yu. Dumanskyi, A. Lyashenko, O. Ivankova, I. Dosenko
    356-360
    30.12.2025
    DOI: https://doi.org/10.15407/exp-oncology.2025.03.356
  • Modern Landscape of Innovative Technologies in Optimizing the Quality of Life of Cancer Patients

    V. CHEKHUN
    281-288
    12.12.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.04.281
  • COMPARISON OF 2D AND 3D PRIMARY CELL CULTURES OBTAINED FROM EXPLANT OF HIGH-GRADE UROTHELIAL BLADDER CANCER

    L.V. Garmanchuk, P.G. Yakovlev, G.V. Ostrovska, Yu.A. Stupak, O.V. Skachkova, O.I. Gorbach, Yu.V. Stepanov
    130-136
    26.06.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.130
  • EXPRESSION PATTERN OF miR-125b-2, -155, -221, AND -320a IS ASSOCIATED WITH RESPONSE OF BREAST CANCER PATIENTS TO TAMOXIFEN

    O. Pridko, T. Borikun, O. Rossylna, M. Rishko, A.V. Rusyn
    295-299
    09.03.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.19152
  • Improving Patients’ Quality of Life After Surgical Treatment of Primary Malignant Bone Tumors Using a Training 3D Model

    O. DROBOTUN, V. PROTSENKO, N. TERNOVYY
    341-344
    12.12.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.04.341
  • ASSESSMENT OF CIRCULATING miRNA LEVELS IN BREAST CANCER PATIENTS DEPENDING ON CLINICAL CHARACTERISTICS AND CHEMOTHERAPY

    О. Harashchenko
    451-456
    12.12.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.451
  • Features of recurrence of endometrioid type endometrial cancer of I stage

    O.M. Movchan, V.S. Svintsitskiy, N.P. Tsip, S.V. Nespryadko, O.I. Bublіieva, N.P. Iurchenko
    365-369
    26.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-4.17052
  • PREDICTIVE POWER OF OXIDATIVE STRESS BIOMARKERS IN RECURRENCE AND SURVIVAL IN ADVANCED CERVICAL CANCER

    Marija Jelic, Aljosa Mandic, Slobodan Maricic, Biljana Bozin, Nebojsa Kladar, Jan Sudji, Branislava Srdjenovic Conic
    231-241
    11.10.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.231
  • Volodymyr Oleksiyovych SHLYAKHOVENKO

    537-538
    12.12.2023
  • Tumor microenvironment and metabolic factors: contribution to gastric cancer

    L. Bubnovskaya, D. Osinsky
    2-10
    01.06.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-1.14056
  • APPENDICULAR MUCINOUS CYSTADENOMA AND CYSTOADENOSARCOMA IN GYNECOLOGICAL PRACTICE. CLINICAL CASES AND LITERATURE REVIEW

    V.О. SKLYAROVА, V.V. MAKSYMYUK, R.A. CHAJKIVSKYJ, O.V. PRYKUPENKO, O.M. NEPYIVODA, T.YU. ROZHANSKYI, YU.T. MARTYN, V.R. CHAJKIVSKA
    108-114
    11.07.2025
    DOI: https://doi.org/10.15407/exp-oncology.2025.01.108
  • EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & −191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA

    Wani Zahoor, Arshad A. Pandith, Syed Nisar, Iqbal Qasim, Menka Surana, Farooq A. Ganie, Usma Manzoor, Sajad H. Arif, Shayaq Ul Abeer Rasool, Adil Lateef, Parveen Shah, Rashid A. Bhat
    203-210
    11.10.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.203
201 - 217 of 217 items << < 4 5 6 7 8 9 

Language

  • Українська
  • English

Make a Submission

Make a Submission

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

More information about the publishing system, Platform and Workflow by OJS/PKP.